<DOC>
	<DOCNO>NCT02948387</DOCNO>
	<brief_summary>Determine antibiotic prophylaxis intravenous cephalosporin aminoglycoside patient Type II II open fracture safe effective .</brief_summary>
	<brief_title>Preventing Infections Orthopaedic Patients</brief_title>
	<detailed_description>1 . Determine safety efficacy antibiotic prophylaxis type II II open fracture use IV Cephalosporin aminoglycoside . 2 . Identify incidence acute kidney injury . 3 . Identify type number associate infection 4 . Identify antibiotic resistance profile note 5 . Identify secondary infection sit fracture site</detailed_description>
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Fractures , Open</mesh_term>
	<criteria>Male Female &gt; = 18 year old Patients diagnose Type II III open fracture Prior treatment , report allergy betalactam aminoglycoside antibiotic pregnancy receive 72 hour IV antibiotic prophylaxis 1st 2nd generation cephalosporin either gentamicin tobramycin receive ongoing inpatient care</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>